Cours Gentian Diagnostics AS Oslo Bors
Actions
NO0010748866
Equipement, fournitures et distribution médicale
CA 2024 * | 174 M 16,04 M 14,49 M | CA 2025 * | 226 M 20,77 M 18,75 M | Capitalisation | 595 M 54,74 M 49,43 M |
---|---|---|---|---|---|
Résultat net 2024 * | 7 M 644 k 581 k | Résultat net 2025 * | 13 M 1,2 M 1,08 M | VE / CA 2024 * | 3,05 x |
Trésorerie nette 2024 * | 63 M 5,79 M 5,23 M | Trésorerie nette 2025 * | 65 M 5,98 M 5,4 M | VE / CA 2025 * | 2,35 x |
PER 2024 * |
77,6
x | PER 2025 * |
44
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 54,85% |
Dernier transcript sur Gentian Diagnostics AS
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Hilja Ibert
CEO | Chief Executive Officer | - | 16/07/18 |
Njaal Kind
DFI | Director of Finance/CFO | 52 | 02/01/18 |
Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Thomas Settevik
CHM | Chairman | 64 | - |
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,89% | 12,56 Md | |
-9,59% | 7,68 Md | |
-1,31% | 5,29 Md | |
+21,82% | 5,18 Md | |
+0,02% | 4,57 Md | |
-50,89% | 3,29 Md | |
+6,42% | 2,6 Md | |
-10,02% | 2,2 Md | |
-8,29% | 1,79 Md |